Absci: Creating Drugs at the Speed of AI
NASDAQ: ABSI | Absci Website
Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.
Most drug discovery approaches today look to existing antibody libraries for incremental improvements; however, Absci designs antibodies “from scratch” on a computer, generating candidates unlike those found in existing databases. Their wet lab can then experimentally validate the candidates that work right out of the computer, potentially reducing the time it takes to get new drug leads into the clinic while unlocking treatments for traditionally “undruggable” diseases and improved therapeutic possibilities for many others.
In this interview with Yolande Lougheed, Absci CEO Sean McClain discusses the company’s collaboration with leading researchers at the California Institute of Technology (Caltech) in a joint effort to discover affordable HIV therapeutic vaccinations, with the goal of making a significant step forward in the fight against the global HIV/AIDS epidemic.
Absci is a Corporate Marketing Partner of IDG. IDG’s Corporate Marketing Programs are for world-class growth companies interested in driving awareness within high value alternative capital channels including family offices. Throughout the year-long program, IDG sets the stage for you to share your story with in-person presentations, video interviews, virtual events, and a comprehensive marketing program.
To learn more about IDG’s Corporate Marketing Program, please contact Steve Davidson.
Disclosure & Disclaimer
International Deal Gateway (“IDG”) has been paid by Absci Corporation. (“Absci”) to provide various marketing and awareness services including posting content and conducting interviews on or through our platform and e-mail subscriber list. We do not own any securities of Absci. You should not make any investment decisions based on our communications.
The information contained herein relating to Absci has been prepared by or on behalf of Absci and the information regarding Absci is being provided to you by IDG at the direction of, and on behalf of Absci.
We are NOT securities dealers or brokers, investment advisors or financial advisors, and you should not rely on the information herein as investment advice. If you are seeking personal investment advice, please contact a qualified and registered broker, investment advisor or financial advisor.
At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. By using our website or platform you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our website / media webpage.
We do not provide personalized or individualized investment advice or advice that is tailored to the needs of any particular recipient. Any information provided as part of the services is impersonal and not specific to any person’s investment needs. You acknowledge and agree that no content published or otherwise provided as part of any service constitutes a personalized recommendation or advice regarding the suitability of, or advisability of investing in, purchasing or selling any particular investment, security, portfolio, commodity, transaction or investment strategy. To the extent that any of the content may be deemed to be investment advice or recommendations in connection with a particular security, such information is impersonal and not tailored to the investment needs of any specific person.
This content (including interviews) may include certain statements that constitute “forward-looking information or statements” and readers and viewers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. There are risks and other factors that could cause actual results and events to vary significantly.
The content disclosed herein is intended to highlight Absci for your further investigation; this is not a stock recommendation or constitute an offer or sale of the referenced securities. The securities of Absci may be considered high risk; if you do invest despite these warnings, you may lose your entire investment. Please do your own research before investing, including reading the company’s SEDAR and SEC filings, press releases, and risk disclosures. It is our policy that information contained in this profile was provided by the company, extracted from SEDAR and SEC filings, company websites, and other publicly available sources. The information in our website / media webpage is believed to be accurate and correct and we have asked Absci to review the contents as it relates to them, but has not been independently verified and is not guaranteed to be correct.
This email does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America.
Certain statements in this press release constitute “forward looking” statements that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance, objectives or achievements of Absci, or industry results, to be materially different from any future results, performance, objectives, or achievements expressed or implied by such forward looking statements. When used in this press release, words such as “may”, “would”, “could”, “will”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan”, and other similar expressions are intended to identify forward-looking statements. These statements reflect Absci’s current views regarding future events and operating performance, are based on information currently available to Absci, and speak only as of the date of this press release.
These forward-looking statements involve a number of risks, uncertainties and assumptions and should not be read as guarantees that future performance or results will be achieved. Many factors could cause the actual results, performance, objectives, or achievements of Absci to be materially different from any future results, performance, objectives, or achievements that may be expressed or implied by such forward looking statements. Additional factors are discussed under the headings “Liquidity and capital resources” and “Risks and Uncertainties” in Absci management’s discussion and analysis, annual information form, and other publicly available disclosure documents, as filed by Absci on SEDAR (www.sedar.com).
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described in this presentation as intended, planned, anticipated, believed, estimated, or expected. Unless required by applicable securities law, Absci does not intend and does not assume any obligation to update these forward-looking statements.